Get the Stockscreener App
15.26
1.42%
-0.22
BlossomHill Therapeutics, Inc. Common Stock Stock (BLSM) Forecast
The BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $18.76, representing a +22.91% increase from the current price of $15.26. The highest analyst price target is $22.65, and the lowest is $14.87.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BLSM Price Target
Average 19.41
(+27.20% Upside)
Is BlossomHill Therapeutics, Inc. Common Stock (BLSM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.18 | Neutral |
| STOCH(9,6) | 12.90 | Buy |
| STOCHRSI(14) | 19.29 | Buy |
| MACD(12,26) | -1.1133 | Sell |
| ADX(14) | 29.97 | Sell |
| William %R | -93.34 | Buy |
| CCI(14) | -66.89 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
17.45
Sell
|
17.41
Sell
|
| MA20 |
20.15
Sell
|
18.69
Sell
|
| MA50 |
18.59
Sell
|
0.00
Buy
|
| MA100 |
9.2955
Buy
|
0.00
Buy
|
| MA200 |
4.6478
Buy
|
0.00
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, BLSM could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 7 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on BLSM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 35.18 indicates that BLSM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.9 indicates that BLSM is oversold. This indicates that BLSM price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.29 indicates that BLSM is oversold. This suggests that BLSM price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.97 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -66.89 indicates that BLSM is still oversold but not to an extreme extent.
Long-term BLSM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about BlossomHill Therapeutics, Inc. Common Stock financial reports and earnings history, BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock could reach $9.0057 by 2030, $23.91 by 2040 and $52.30 by 2050. See the projected annual prices until 2050 of the BlossomHill Therapeutics, Inc. Common Stock stock below:
- BlossomHill Therapeutics, Inc. Common Stock (BLSM) is expected to reach an average price of $5.3315 in 2035, with a high prediction of $9.11 and a low estimate of $8.6125. This indicates an $-65.06% rise from the last recorded price of $15.26.
- BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock is projected to chart a bullish course in 2040, with an average price target of $21.09, representing an $38.21% surge from its current level. The forecast ranges from a conservative $21.81 to a sky-high $23.91.
- Our analysts predict BlossomHill Therapeutics, Inc. Common Stock (BLSM) to jump 108.23% by 2045, soaring from $35.81 to an average price of $31.78, potentially reaching $37.60. While $35.81 is the low estimate, the potential upside is significant.
- BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock is expected to climb by 2050, reaching an average of $47.22, a $209.40% jump from its current level. However, a wide range of estimates exists, with high and low targets of $52.30 and $47.40, respectively, highlighting the market's uncertainty.
BlossomHill Therapeutics, Inc. Common Stock Stock (BLSM) Year by Year Forecast
BlossomHill Therapeutics, Inc. Common Stock Stock (BLSM) Price Forecast for 2026
The predicted value for BlossomHill Therapeutics, Inc. Common Stock (BLSM) in 2026 is set at an average of $21.25. Estimates vary from a peak of $27.99 to a trough of $14.51, indicating an +39.25% surge from the present price of $15.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $20.14 | $14.87 | $22.65 | +31.95% |
| December, 2026 | $18.98 | $17.56 | $27.27 | +24.35% |
BlossomHill Therapeutics, Inc. Common Stock Stock (BLSM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for BlossomHill Therapeutics, Inc. Common Stock (BLSM) is $19.05, with a high forecast of $26.55 and a low forecast of $11.55. This indicates an +24.84% increase from the last price of $15.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $14.71 | $13.77 | $19.39 | -3.64% |
| February, 2027 | $20.56 | $14.13 | $20.71 | +34.71% |
| March, 2027 | $18.26 | $16.84 | $26.55 | +19.68% |
| April, 2027 | $13.97 | $13.03 | $18.68 | -8.47% |
| May, 2027 | $18.69 | $13.40 | $21.20 | +22.46% |
| June, 2027 | $17.55 | $16.13 | $25.83 | +15.00% |
| July, 2027 | $13.23 | $12.29 | $17.97 | -13.30% |
| August, 2027 | $17.96 | $12.66 | $20.47 | +17.71% |
| September, 2027 | $16.84 | $15.42 | $25.11 | +10.32% |
| October, 2027 | $12.49 | $11.55 | $17.26 | -18.13% |
| November, 2027 | $17.24 | $11.93 | $19.75 | +12.97% |
| December, 2027 | $16.12 | $14.70 | $24.40 | +5.65% |
BlossomHill Therapeutics, Inc. Common Stock Stock (BLSM) Price Forecast for 2028
In 2028, BlossomHill Therapeutics, Inc. Common Stock (BLSM) is projected to reach an average price of $16.13, with a high projection of $23.68 and a low estimate of $8.59. This indicates an +5.72% rise from the last price of $15.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $11.97 | $10.81 | $16.55 | -21.55% |
| February, 2028 | $16.51 | $11.54 | $19.02 | +8.22% |
| March, 2028 | $15.41 | $13.99 | $23.68 | +0.97% |
| April, 2028 | $11.02 | $10.07 | $15.84 | -27.80% |
| May, 2028 | $15.79 | $10.46 | $18.30 | +3.48% |
| June, 2028 | $14.69 | $13.27 | $22.96 | -3.71% |
| July, 2028 | $10.50 | $9.33 | $15.13 | -31.18% |
| August, 2028 | $15.07 | $10.08 | $17.58 | -1.27% |
| September, 2028 | $13.98 | $12.56 | $22.24 | -8.38% |
| October, 2028 | $9.7674 | $8.59 | $14.42 | -35.99% |
| November, 2028 | $14.34 | $9.3461 | $16.85 | -6.01% |
| December, 2028 | $13.27 | $11.85 | $21.52 | -13.06% |
BlossomHill Therapeutics, Inc. Common Stock Stock (BLSM) Price Forecast for 2029
The 2029 price forecast for BlossomHill Therapeutics, Inc. Common Stock Stock (BLSM) is $13.22 on average, with a high prediction of $20.80 and a low estimate of $5.63. This represents an -13.40% decrease from the previous price of $15.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.0327 | $7.85 | $13.71 | -40.81% |
| February, 2029 | $13.62 | $8.614 | $16.13 | -10.76% |
| March, 2029 | $12.55 | $11.13 | $20.80 | -17.74% |
| April, 2029 | $8.2979 | $7.11 | $12.99 | -45.62% |
| May, 2029 | $12.89 | $7.8819 | $15.40 | -15.51% |
| June, 2029 | $11.84 | $10.42 | $20.08 | -22.41% |
| July, 2029 | $7.5632 | $6.37 | $12.28 | -50.44% |
| August, 2029 | $12.17 | $7.1498 | $14.68 | -20.25% |
| September, 2029 | $11.13 | $9.7059 | $19.36 | -27.09% |
| October, 2029 | $6.8284 | $5.63 | $11.57 | -55.25% |
| November, 2029 | $11.45 | $6.4177 | $13.96 | -25.00% |
| December, 2029 | $8.2365 | $6.8765 | $18.64 | -46.03% |
BlossomHill Therapeutics, Inc. Common Stock Stock (BLSM) Price Forecast for 2030
BlossomHill Therapeutics, Inc. Common Stock Stock (BLSM) is expected to reach an average price of $10.30 in 2030, with a high forecast of $17.92 and a low forecast of $2.67. This signifies an -32.52% decrease from the last price of $15.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.0937 | $4.89 | $9.0057 | -60.07% |
| February, 2030 | $10.72 | $5.6856 | $13.23 | -29.74% |
| March, 2030 | $9.6986 | $8.2786 | $17.92 | -36.44% |
| April, 2030 | $5.359 | $4.15 | $10.15 | -64.88% |
| May, 2030 | $9.9969 | $4.9535 | $12.51 | -34.49% |
| June, 2030 | $8.9849 | $7.5649 | $17.21 | -41.12% |
| July, 2030 | $4.6242 | $3.41 | $9.4394 | -69.70% |
| August, 2030 | $9.2727 | $4.2214 | $11.78 | -39.24% |
| September, 2030 | $6.1034 | $4.7434 | $16.49 | -60.00% |
| October, 2030 | $3.8895 | $2.67 | $6.8805 | -74.51% |
| November, 2030 | $8.5485 | $3.4893 | $11.06 | -43.98% |
| December, 2030 | $5.3923 | $4.0323 | $15.77 | -64.66% |
1.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):